chartexchange

ZYME
Zymeworks Inc.
stockNASDAQ

At CloseNov 18, 2026 3:59:56 PM EST
26.04USD+0.774%(+0.20)1,085,751
Pre-marketNov 18, 2026 9:08:30 AM EST
25.61USD-0.890%(-0.23)
After-hoursNov 18, 2026 4:01:30 PM EST
26.20USD+0.614%(+0.16)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Vancouver, BC, Canada
Previous Close
$25.84
Beta
0.91
52-Week High
$31.97 2026-11-10
52-Week Low
$21.52 2026-08-03
SMA 50
$27.20
SMA 200
$25.57
Avg. Vol 10D
1.07M
Avg. Vol 30D
1.31M
Avg. Vol 90D
906,460
Relative Vol
0.83
67.02M
0.4100%
2,000,000
Mar 4, 2027 (105d)
ZYME Profile

zymeworks is a privately held biotherapeutics company that is developing best-in-class azymetric™ bi specific antibodies and antibody drug conjugates for the treatment of oncology, autoimmunity and inflammatory diseases. the company's novel azymetric™ and albucore™ platforms, and its proprietary zymecad™ structure-guided protein engineering technology, enable the development of highly potent bi-specific antibodies and multivalent protein therapeutics targeted across a range of indications. zymeworks is focused on accelerating its preclinical biotherapeutics pipeline through in-house research and development programs and strategic collaborations. more information on zymeworks can be found at www.zymeworks.com.

ZYME Performance
PeriodPriceDateChangeBeta
1W26.472026-11-12-1.59%-0.327
1M25.542026-10-19+2.00%1.145
3M27.212026-08-19-4.26%1.145
6M24.402026-05-19+6.76%0.978
1Y22.602025-11-19+15.27%0.910
2Y14.772024-11-19+76.37%—
5Y19.812021-11-19+31.50%0.918
ZYME Stock Summary

Zymeworks Inc. (NASDAQ:ZYME) stock price today is $26.05, and today's volume is 1,085,751. ZYME is up 0.813% today. The 30 day average volume is 1.31M. ZYME market cap is $1.83B with 70.12M shares outstanding.